{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:31:27Z","timestamp":1793723487264,"version":"4.6.1"},"reference-count":99,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2020,3,3]]},"DOI":"10.1080\/14760584.2020.1745636","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T03:52:05Z","timestamp":1585626725000},"page":"279-292","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":101,"title":["Army Liposome Formulation (ALF) family of vaccine adjuvants"],"prefix":"10.1080","volume":"19","author":[{"given":"Carl R.","family":"Alving","sequence":"first","affiliation":[{"name":"Laboratory of Adjuvant & Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research","place":["Silver Spring, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina K.","family":"Peachman","sequence":"additional","affiliation":[{"name":"Laboratory of Adjuvant & Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research","place":["Silver Spring, USA"]},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","place":["Bethesda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Matyas","sequence":"additional","affiliation":[{"name":"Laboratory of Adjuvant & Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research","place":["Silver Spring, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Rao","sequence":"additional","affiliation":[{"name":"Laboratory of Adjuvant & Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research","place":["Silver Spring, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Beck","sequence":"additional","affiliation":[{"name":"Laboratory of Adjuvant & Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research","place":["Silver Spring, USA"]},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","place":["Bethesda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1383159"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED.170.4S.3"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxj003"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01397"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1953.02940140013005"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-196404000-00001"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1962.03050080006002"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(86)90005-8"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.03.008"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb44015.x"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(03)73003-1"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2014.12.005"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00058-U"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00166-4"},{"key":"e_1_3_6_17_1","unstructured":"FDA. 2019 [cited 2019 Aug 10]. Available from: https:\/\/www\/fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/common-ingredients-us-licensed-vaccines"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.6.5.723"},{"key":"e_1_3_6_19_1","unstructured":"Vandepapeliere P inventor; Vaccine compositions comprising a saponin adjuvant. patent 10 143 745. 2018."},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"e_1_3_6_21_1","unstructured":"Association American Pharmacist. 2019 [cited 2019 Oct 16]. Available from: https:\/\/www.pharmacist.com\/shigles-vaccine-shortage-apha-recommends-patients-take-these-9-steps"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.1.358"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.2.361"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1995.11.1279"},{"issue":"1","key":"e_1_3_6_25_1","first-page":"S47","article-title":"Safety evaluation of vaccine adjuvant: national cooperative vaccine development meeting working group","volume":"9","author":"Goldenthal K","year":"1993","unstructured":"Goldenthal K, Cavagnaro JA, Alving CR, et al. Safety evaluation of vaccine adjuvant: national cooperative vaccine development meeting working group. AIDS Res Hum Retroviruses. 1993;9(Suppl 1):S47\u2013S51.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/1044-579X(95)90007-1"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy348"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908492"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008764"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113425"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2012.0103"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11519"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087572"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-052912-123749"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1276138"},{"key":"e_1_3_6_36_1","doi-asserted-by":"crossref","unstructured":"Duerr R Gorny MK.\u00a0V2-Specific Antibodies in HIV-1 vaccbine research and natural infection: controllers or surrogate markers.\u00a0Vaccines (Basel).\u00a02019\u00a0Aug 6;7(3):E82","DOI":"10.3390\/vaccines7030082"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.049"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.142"},{"key":"e_1_3_6_39_1","unstructured":"European Medicines Agency. First malaria vaccine receives positive scientific opinion from EMA. 2015 [2019 Oct 10]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/first-malaria-vaccine-recieves-positive-scientific-opinion-ema"},{"key":"e_1_3_6_40_1","unstructured":"World Heatlth Organization. Update on RTS S Malaria Vaccine Implementation Programme. Geneva Switzerland 2019 [cited 2019 Oct 10]. Available from: https:\/\/www.who.int\/malria\/mpac\/mpac-april2019-session3-rtss-mvip-update.pdf?ua=1"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208394"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209744"},{"key":"e_1_3_6_43_1","unstructured":"Alving C Beck Z inventors; Non-toxic adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing liposome composition and a saponin. US patent 10434167. 2019 2019 Oct 8."},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2017.02.015"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.001"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2018.1538239"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.3934\/matersci.2019.2.200"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.49.1.225-237.1985"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a135294"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.8.2.8119492"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2017.07.008"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1004"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.60.6.2438-2444.1992"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(99)00064-2"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.35"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.10.028"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(03)73010-9"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.11.021"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.02.006"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.070"},{"key":"e_1_3_6_62_1","first-page":"3","article-title":"Enhanced immunogenicity and protective efficacy of a campylobacter jejuni conjugate vaccine coadministered with liposomes containing monophosphoryl lipid A and QS-21","volume":"4","author":"Ramakrishnan A","year":"2019","unstructured":"Ramakrishnan A, Schumack NM, Gariepy CL, et al. Enhanced immunogenicity and protective efficacy of a campylobacter jejuni conjugate vaccine coadministered with liposomes containing monophosphoryl lipid A and QS-21. mSphere. 2019 May 1;4:3:e00101-19.","journal-title":"mSphere"},{"issue":"3","key":"e_1_3_6_63_1","article-title":"Enhanced immunogenicity and protective efficacy of a campylobacter jejuni conjugate vaccine coadministered with liposomes containing monophosphoryl lipid A and QS-21\u201d","volume":"4","author":"Ramakrishnan A","year":"2019","unstructured":"Ramakrishnan A, Schumack NM, Gariepy CL, et al. Correction for Ramakrishnan et al. Enhanced immunogenicity and protective efficacy of a campylobacter jejuni conjugate vaccine coadministered with liposomes containing monophosphoryl lipid A and QS-21\u201d. mSphere. 2019 May 22;4(3):e00351-19.","journal-title":"mSphere"},{"issue":"3","key":"e_1_3_6_64_1","article-title":"Enhanced immunogenicity and protective efficacy of a campylobacter jejuni conjugate vaccine coadministered with liposomes containing monophosphoryl lipid A and QS-21\u201d","volume":"4","author":"Ramakrishnan A","year":"2019","unstructured":"Ramakrishnan A, Schumack NM, Gariepy CL, et al. Erratum for Ramakrishnan et al. Enhanced immunogenicity and protective efficacy of a campylobacter jejuni conjugate vaccine coadministered with liposomes containing monophosphoryl lipid A and QS-21\u201d. mSphere. 2019 Jun 26;4(3):e00440-19.","journal-title":"mSphere"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02150"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00205743"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.61.12.5252-5260.1993"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(89)90274-0"},{"key":"e_1_3_6_69_1","unstructured":"FDA. 2012 [updated 2018 Mar 22; cited 2019 Oct 20]. Available from: https:www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/guidance-industry-pyrogen-and-endotoxins-testing-questions-and-answers#_ftn1"},{"issue":"3","key":"e_1_3_6_70_1","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.4049\/jimmunol.130.3.1390","article-title":"Antibodies reactive with liposomal phospholipids are produced during experimental Trypanosoma rhodesiense infections in rabbits","volume":"130","author":"Richards RL","year":"1983","unstructured":"Richards RL, Aronson J, Schoenbechler M, et al. Antibodies reactive with liposomal phospholipids are produced during experimental Trypanosoma rhodesiense infections in rabbits. J Immunol. 1983 Mar;130(3):1390\u20131394.","journal-title":"J Immunol"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.059"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.02.040"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.061"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00174-3"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw237"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00412-15"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/82225"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600674"},{"issue":"6","key":"e_1_3_6_79_1","first-page":"1434","article-title":"Van de Verg LL. Combination vaccines against diarrheal diseases","volume":"11","author":"Venkatesan MM","year":"2015","unstructured":"Venkatesan MM. Van de Verg LL. Combination vaccines against diarrheal diseases. Hum Vaccin Immunother. 2015;11(6):1434\u20131448.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3858-x"},{"key":"e_1_3_6_81_1","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2019 Book 1. Executive Summary. 2019. (E.19.XI.8 UNpSN editor.)."},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.027"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01427"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-018-1060-4"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.04.025"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.084"},{"issue":"4","key":"e_1_3_6_87_1","first-page":"439","article-title":"Immunologic approaches to the treatment of prostate cancer","volume":"26","author":"Harris DT","year":"1999","unstructured":"Harris DT, Matyas GR, Gomella LG, et al. Immunologic approaches to the treatment of prostate cancer. Semin Oncol. 1999 Aug;26(4):439\u2013447.","journal-title":"Semin Oncol"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0213"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000493"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072301"},{"key":"e_1_3_6_91_1","unstructured":"AC Immune Pipeline 2019 cited 2019 Nov 11. Available from: https:\/\/www.acimmune.com\/en\/alzheimer-s-disease-ad\/"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803484"},{"issue":"6","key":"e_1_3_6_93_1","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.4049\/jimmunol.123.6.2558","article-title":"Lipid A from endotoxin: antigenic activities of purified fractions in liposomes","volume":"123","author":"Banerji B","year":"1979","unstructured":"Banerji B, Alving CR. Lipid A from endotoxin: antigenic activities of purified fractions in liposomes. J Immunol. 1979 Dec;123(6):2558\u20132562.","journal-title":"J Immunol"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.085"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0013-9"},{"key":"e_1_3_6_96_1","unstructured":"Alving C Matyas G Mayorov A et al. inventors Induction of highly specific antibodies to a hapten but not to a carrier peptide by immunization. US patent 9193739. 2015."},{"key":"e_1_3_6_97_1","unstructured":"GlaxoSmithKline package insert for Shingrix. Highlights of prescribing information. 2019. Available from: https:\/\/gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Shingrix\/pdf\/SHINGRIX.PDF"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.02.015"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0132-6"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2015.1067198"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat9120"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2020.1745636","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14760584.2020.1745636","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2020.1745636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:12:26Z","timestamp":1793722346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2020.1745636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,3]]}},"alternative-id":["10.1080\/14760584.2020.1745636"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2020.1745636","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}